Fox Run Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$216K Buy
2024
Q4
Sell
2024
Q3
$1.46M Buy
2024
Q2
Sell
2024
Q1
$365K Buy
2019
Q1
Sell
2018
Q4
$747K Buy
2018
Q3
$353K Sell
2018
Q2
$906K Buy
2017
Q2
Sell
2017
Q1
$351K Buy
2016
Q4
$285K Buy
2016
Q3
Sell
2016
Q2
$392K Sell
2016
Q1
$730K Buy